Format

Send to

Choose Destination
Curr Opin Pharmacol. 2016 Feb;26:10-5. doi: 10.1016/j.coph.2015.09.007. Epub 2015 Sep 29.

Reprogramming of macrophages--new opportunities for therapeutic targeting.

Author information

1
Genomics & Immunoregulation, LIMES-Institute, University of Bonn, Carl-Troll-Str. 31, D-53115 Bonn, Germany. Electronic address: j.schultze@uni-bonn.de.

Abstract

Macrophages are key players of tissue homeostasis and are cells involved in all major human diseases including infections, tumors, western life-style associated diseases and even neurodegenerative diseases. Therefore, specifically targeting macrophages seems to be an attractive therapeutic approach, yet such strategies have not been successfully translated to the clinic. An important hallmark of macrophages is their astounding plasticity and their capacity to integrate microenvironmental signals to perform distinct biological functions. Understanding the cellular programming of macrophages during such events will be a fundamental pre-requisite to develop targeted therapeutic approaches in human diseases. Here, I highlight recent findings of how macrophage activation is regulated and how one can envision much more specific approaches of targeting macrophages.

PMID:
26426255
DOI:
10.1016/j.coph.2015.09.007
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center